^PDB: 3N7S; ter Haar E, Koth CM, Abdul-Manan N, Swenson L, Coll JT, Lippke JA, Lepre CA, Garcia-Guzman M, Moore JM (2010). „Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonism”. Structure. 18 (9): 1083—93. PMID20826335. doi:10.1016/j.str.2010.05.014.
^Aiyar N, Rand K, Elshourbagy NA, Zeng Z, Adamou JE, Bergsma DJ, Li Y (1996). „A cDNA encoding the calcitonin gene-related peptide type 1 receptor”. J. Biol. Chem. 271 (19): 11325—9. PMID8626685. doi:10.1074/jbc.271.19.11325.
^McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, Foord SM (1998). „RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor”. Nature. 393 (6683): 333—9. PMID9620797. doi:10.1038/30666.
^Kamitani S, Asakawa M, Shimekake Y, Kuwasako K, Nakahara K, Sakata T (1999). „The RAMP2/CRLR complex is a functional adrenomedullin receptor in human endothelial and vascular smooth muscle cells”. FEBS Lett. 448 (1): 111—4. PMID10217420. doi:10.1016/S0014-5793(99)00358-0.
^„Receptor properties”. SenseLab Project: Membrane properties resource. Yale University. Архивирано из оригинала 28. 02. 2009. г. Приступљено 28. 09. 2008.
Literatura
Born W, Muff R, Fischer JA (2002). „Functional interaction of G protein-coupled receptors of the adrenomedullin peptide family with accessory receptor-activity-modifying proteins (RAMP).”. Microsc. Res. Tech. 57 (1): 14—22. PMID11921352. doi:10.1002/jemt.10051.
Yallampalli C; Chauhan M; Thota CS; et al. (2003). „Calcitonin gene-related peptide in pregnancy and its emerging receptor heterogeneity.”. Trends Endocrinol. Metab. 13 (6): 263—9. PMID12128288.
Foord SM, Craig RK (1988). „Isolation and characterisation of a human calcitonin-gene-related-peptide receptor.”. Eur. J. Biochem. 170 (1-2): 373—9. PMID2826160. doi:10.1111/j.1432-1033.1987.tb13710.x.
Skofitsch G, Jacobowitz DM (1986). „Autoradiographic distribution of 125I calcitonin gene-related peptide binding sites in the rat central nervous system.”. Peptides. 6 (5): 975—86. PMID3001670. doi:10.1016/0196-9781(85)90331-6.
Flühmann B; Muff R; Hunziker W; et al. (1995). „A human orphan calcitonin receptor-like structure.”. Biochem. Biophys. Res. Commun. 206 (1): 341—7. PMID7818539. doi:10.1006/bbrc.1995.1047.
Aiyar N; Rand K; Elshourbagy NA; et al. (1996). „A cDNA encoding the calcitonin gene-related peptide type 1 receptor.”. J. Biol. Chem. 271 (19): 11325—9. PMID8626685. doi:10.1074/jbc.271.19.11325.
McLatchie LM; Fraser NJ; Main MJ; et al. (1998). „RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor.”. Nature. 393 (6683): 333—9. PMID9620797. doi:10.1038/30666.
Sams A, Jansen-Olesen I (1999). „Expression of calcitonin receptor-like receptor and receptor-activity-modifying proteins in human cranial arteries.”. Neurosci. Lett. 258 (1): 41—4. PMID9876047. doi:10.1016/S0304-3940(98)00844-1.
Kamitani S; Asakawa M; Shimekake Y; et al. (1999). „The RAMP2/CRLR complex is a functional adrenomedullin receptor in human endothelial and vascular smooth muscle cells.”. FEBS Lett. 448 (1): 111—4. PMID10217420. doi:10.1016/S0014-5793(99)00358-0.
Aldecoa A, Gujer R, Fischer JA, Born W (2000). „Mammalian calcitonin receptor-like receptor/receptor activity modifying protein complexes define calcitonin gene-related peptide and adrenomedullin receptors in Drosophila Schneider 2 cells.”. FEBS Lett. 471 (2-3): 156—60. PMID10767413. doi:10.1016/S0014-5793(00)01387-9.
Frayon S; Cueille C; Gnidéhou S; et al. (2000). „Dexamethasone increases RAMP1 and CRLR mRNA expressions in human vascular smooth muscle cells.”. Biochem. Biophys. Res. Commun. 270 (3): 1063—7. PMID10772950. doi:10.1006/bbrc.2000.2552.
Kuwasako K; Shimekake Y; Masuda M; et al. (2000). „Visualization of the calcitonin receptor-like receptor and its receptor activity-modifying proteins during internalization and recycling.”. J. Biol. Chem. 275 (38): 29602—9. PMID10882736. doi:10.1074/jbc.M004534200.
Evans BN; Rosenblatt MI; Mnayer LO; et al. (2000). „CGRP-RCP, a novel protein required for signal transduction at calcitonin gene-related peptide and adrenomedullin receptors.”. J. Biol. Chem. 275 (40): 31438—43. PMID10903324. doi:10.1074/jbc.M005604200.
Hilairet S, Foord SM, Marshall FH, Bouvier M (2001). „Protein-protein interaction and not glycosylation determines the binding selectivity of heterodimers between the calcitonin receptor-like receptor and the receptor activity-modifying proteins.”. J. Biol. Chem. 276 (31): 29575—81. PMID11387328. doi:10.1074/jbc.M102722200.
Kamitani S, Sakata T (2001). „Glycosylation of human CRLR at Asn123 is required for ligand binding and signaling.”. Biochim. Biophys. Acta. 1539 (1-2): 131—9. PMID11389975. doi:10.1016/S0167-4889(01)00100-8.
Nikitenko LL; Brown NS; Smith DM; et al. (2001). „Differential and cell-specific expression of calcitonin receptor-like receptor and receptor activity modifying proteins in the human uterus.”. Mol. Hum. Reprod. 7 (7): 655—64. PMID11420389. doi:10.1093/molehr/7.7.655.
Hilairet S; Bélanger C; Bertrand J; et al. (2001). „Agonist-promoted internalization of a ternary complex between calcitonin receptor-like receptor, receptor activity-modifying protein 1 (RAMP1), and beta-arrestin.”. J. Biol. Chem. 276 (45): 42182—90. PMID11535606. doi:10.1074/jbc.M107323200.
Aiyar N, Disa J, Pullen M, Nambi P (2002). „Receptor activity modifying proteins interaction with human and porcine calcitonin receptor-like receptor (CRLR) in HEK-293 cells.”. Mol. Cell. Biochem. 224 (1-2): 123—33. PMID11693189. doi:10.1023/A:1011907328682.
Hagner S; Haberberger RV; Overkamp D; et al. (2002). „Expression and distribution of calcitonin receptor-like receptor in human hairy skin.”. Peptides. 23 (1): 109—16. PMID11814625. doi:10.1016/S0196-9781(01)00586-1.
Spoljašnje veze
„Calcitonin receptors: CALCRL”. IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology.